Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,217 | -37,915 | -20,082 | -9,183 | -28,419 |
| Depreciation Amortization | 313 | 300 | 287 | 273 | 2,613 |
| Accounts receivable | -458 | -461 | -475 | -655 | -1,069 |
| Accounts payable and accrued liabilities | 4,213 | 3,535 | 216 | 955 | 473 |
| Other Working Capital | 3,419 | 3,442 | -1,734 | -1,126 | 1,207 |
| Other Operating Activity | 1,210 | 864 | 3,010 | 1,030 | 4,427 |
| Operating Cash Flow | $-45,521 | $-30,236 | $-18,778 | $-8,706 | $-20,768 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -31 | -31 | -24 | -41 |
| Purchase Sale Intangibles | -587 | -193 | -213 | -97 | -439 |
| Other Investing Activity | -576 | -193 | -202 | -97 | -543 |
| Investing Cash Flow | $-607 | $-224 | $-233 | $-121 | $-584 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 500 |
| Debt Repayment | N/A | N/A | N/A | N/A | -5,192 |
| Common Stock Issued | 43,298 | 43,268 | 374 | 40 | 78,681 |
| Financing Cash Flow | $43,298 | $43,268 | $374 | $40 | $73,989 |
| Beginning Cash Position | 54,191 | 54,191 | 54,191 | 54,191 | 1,554 |
| End Cash Position | 51,362 | 66,999 | 35,554 | 45,404 | 54,191 |
| Net Cash Flow | $-2,830 | $12,808 | $-18,637 | $-8,787 | $52,638 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,521 | -30,236 | -18,778 | -8,706 | -20,768 |
| Capital Expenditure | -31 | -31 | -31 | -24 | -41 |
| Free Cash Flow | -45,552 | -30,267 | -18,809 | -8,730 | -20,809 |